ReP USP - Resultado da busca

Artigo de periodico
Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: a single‐arm prospective study (2023)
Cunha, Mateus Trinconi ; Borges, Ana Paula de Souza ; Carvalho, Vinicius Jardim ; Fujita, André ; Castro Junior, Gilberto de Castro
Source: Cancer Medicine. Unidades: IME, FM, BIOINFORMÁTICA
Subjects: APRENDIZADO COMPUTACIONAL, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Mateus Trinconi et al. Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: a single‐arm prospective study. Cancer Medicine, v. 12, n. 4, p. 5099-5109, 2023Tradução . . Disponível em: https://doi.org/10.1002/cam4.5254. Acesso em: 06 nov. 2024.
APA
Cunha, M. T., Borges, A. P. de S., Carvalho, V. J., Fujita, A., & Castro Junior, G. de C. (2023). Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: a single‐arm prospective study. Cancer Medicine, 12( 4), 5099-5109. doi:10.1002/cam4.5254
NLM
Cunha MT, Borges AP de S, Carvalho VJ, Fujita A, Castro Junior G de C. Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: a single‐arm prospective study [Internet]. Cancer Medicine. 2023 ; 12( 4): 5099-5109.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/cam4.5254
Vancouver
Cunha MT, Borges AP de S, Carvalho VJ, Fujita A, Castro Junior G de C. Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: a single‐arm prospective study [Internet]. Cancer Medicine. 2023 ; 12( 4): 5099-5109.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/cam4.5254
Parte de monografia/livro
Protocolo de preservação de órgão não cirúrgico (2022)
Castro Junior, Gilberto de Castro
Source: Laringologia e vozn. Unidade: FM
Subjects: NEOPLASIAS LARÍNGEAS, RADIOTERAPIA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO JUNIOR, Gilberto de Castro. Protocolo de preservação de órgão não cirúrgico. Laringologia e vozn. Tradução . Rio de Janeiro: Thieme Revinter, 2022. . . Acesso em: 06 nov. 2024.
APA
Castro Junior, G. de C. (2022). Protocolo de preservação de órgão não cirúrgico. In Laringologia e vozn. Rio de Janeiro: Thieme Revinter.
NLM
Castro Junior G de C. Protocolo de preservação de órgão não cirúrgico. In: Laringologia e vozn. Rio de Janeiro: Thieme Revinter; 2022. [citado 2024 nov. 06 ]
Vancouver
Castro Junior G de C. Protocolo de preservação de órgão não cirúrgico. In: Laringologia e vozn. Rio de Janeiro: Thieme Revinter; 2022. [citado 2024 nov. 06 ]
Artigo de periodico
Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial (2022)
Kauark-Fontes, Elisa; Migliorati, Cesar Augusto; Epstein, Joel B; Treister, Nathaniel Simon; Alves, Carolina Guimaraes Bonfim; Faria, Karina Morais; Palmier, Natalia Rangel; Rodrigues-Oliveira, Leticia; Paglioni, Mariana de Pauli; Castro Junior, Gilberto de Castro
Source: Supportive care in cancer. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, MIOSITE, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAUARK-FONTES, Elisa et al. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, v. 30, n. 3, p. 2225-2236, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00520-021-06625-8. Acesso em: 06 nov. 2024.
APA
Kauark-Fontes, E., Migliorati, C. A., Epstein, J. B., Treister, N. S., Alves, C. G. B., Faria, K. M., et al. (2022). Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, 30( 3), 2225-2236. doi:10.1007/s00520-021-06625-8
NLM
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-021-06625-8
Vancouver
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-021-06625-8
Artigo de periodico
Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score (2022)
Burtness, Barbara; Rischin, Danny; Greil, Richard; Soulieres, Denis; Tahara, Makoto; Castro Junior, Gilberto de Castro ; Psyrri, Amanda; Brana, Irene; Baste, Neus; Neupane, Prakash
Source: Journal of clinical oncology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, QUIMIOTERAPIA, CARCINOMA DE CÉLULAS ESCAMOSAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURTNESS, Barbara et al. Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score. Journal of clinical oncology, v. 40, n. 21, p. 2321-2334, 2022Tradução . . Disponível em: https://doi.org/10.1200/JCO.21.02198. Acesso em: 06 nov. 2024.
APA
Burtness, B., Rischin, D., Greil, R., Soulieres, D., Tahara, M., Castro Junior, G. de C., et al. (2022). Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score. Journal of clinical oncology, 40( 21), 2321-2334. doi:10.1200/JCO.21.02198
NLM
Burtness B, Rischin D, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Baste N, Neupane P. Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score [Internet]. Journal of clinical oncology. 2022 ; 40( 21): 2321-2334.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1200/JCO.21.02198
Vancouver
Burtness B, Rischin D, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Baste N, Neupane P. Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score [Internet]. Journal of clinical oncology. 2022 ; 40( 21): 2321-2334.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1200/JCO.21.02198
Artigo de periodico
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 (2022)
Rischin, Danny; Harrington, Kevin J; Greil, Richard; Soulieres, Denis; Tahara, Makoto; Castro Junior, Gilberto de Castro ; Psyrri, Amanda; Brana, Irene; Neupane, Prakash; Bratland, Ase
Source: Oral oncology. Unidade: FM
Subjects: RECIDIVA LOCAL DE NEOPLASIA, NEOPLASIAS DE CABEÇA E PESCOÇO, RECIDIVA LOCAL DE NEOPLASIA, ENSAIO CLÍNICO, QUIMIOTERAPIA, IMUNOTERAPIA, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RISCHIN, Danny et al. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048. Oral oncology, v. 128, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2022.105815. Acesso em: 06 nov. 2024.
APA
Rischin, D., Harrington, K. J., Greil, R., Soulieres, D., Tahara, M., Castro Junior, G. de C., et al. (2022). Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048. Oral oncology, 128. doi:10.1016/j.oraloncology.2022.105815
NLM
Rischin D, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 [Internet]. Oral oncology. 2022 ; 128[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.105815
Vancouver
Rischin D, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 [Internet]. Oral oncology. 2022 ; 128[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.105815
Artigo de periodico
Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells (2022)
Silva, Luan Cesar; Borgato, Gabriell Bonifacio; Wagner, Vivian Petersen; Martins, Manoela Domingues; Rocha, Guilherme Zweig; Lopes, Marcio Ajudarte; Santos-Silva, Alan Roger; Castro Junior, Gilberto de Castro ; Kowalski, Luiz Paulo; Nor, Jacques E.
Source: Journal of oral pathology & medicine. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, SALIVA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Luan Cesar et al. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells. Journal of oral pathology & medicine, v. 51, n. 6, p. 553-562, 2022Tradução . . Disponível em: https://doi.org/10.1111/jop.13252. Acesso em: 06 nov. 2024.
APA
Silva, L. C., Borgato, G. B., Wagner, V. P., Martins, M. D., Rocha, G. Z., Lopes, M. A., et al. (2022). Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells. Journal of oral pathology & medicine, 51( 6), 553-562. doi:10.1111/jop.13252
NLM
Silva LC, Borgato GB, Wagner VP, Martins MD, Rocha GZ, Lopes MA, Santos-Silva AR, Castro Junior G de C, Kowalski LP, Nor JE. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells [Internet]. Journal of oral pathology & medicine. 2022 ; 51( 6): 553-562.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/jop.13252
Vancouver
Silva LC, Borgato GB, Wagner VP, Martins MD, Rocha GZ, Lopes MA, Santos-Silva AR, Castro Junior G de C, Kowalski LP, Nor JE. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells [Internet]. Journal of oral pathology & medicine. 2022 ; 51( 6): 553-562.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/jop.13252
Parte de monografia/livro-apres/pref/posf
Noções de oncologia torácica (2021)
Bitton, Rafael Caparica; Castro Junior, Gilberto de Castro
Source: Cirurgia torácica. Unidade: FM
Subjects: NEOPLASIAS PULMONARES, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTON, Rafael Caparica e CASTRO JUNIOR, Gilberto de Castro. Noções de oncologia torácica. Cirurgia torácica. Rio de Janeiro: Atheneu. . Acesso em: 06 nov. 2024. , 2021
APA
Bitton, R. C., & Castro Junior, G. de C. (2021). Noções de oncologia torácica. Cirurgia torácica. Rio de Janeiro: Atheneu.
NLM
Bitton RC, Castro Junior G de C. Noções de oncologia torácica. Cirurgia torácica. 2021 ;[citado 2024 nov. 06 ]
Vancouver
Bitton RC, Castro Junior G de C. Noções de oncologia torácica. Cirurgia torácica. 2021 ;[citado 2024 nov. 06 ]
Trabalho de evento-resumo periodico
Baseline glycolytic tumor burden predicts response and survival in NSCLC and melanoma patients treated with immune checkpoint inhibitors (2021)
Cordeiro, Saulo da Silva; Wanderley, Carlos Wagner de Souza ; Marin, José Flavio Gomes; Macedo, Mariana de; Nascimento, Ellen; Antonacio, Fernanda Fronzoni; Cunha, Fernando de Queiroz ; Castro Junior, Gilberto de Castro
Source: Journal for ImmunoTherapy of Cancer. Conference titles: Annual Meeting of Society for Immunotherapy of Cancer's. Unidades: FMRP, FM
Subjects: EXONS, LINFÓCITOS, MELANOMA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, Saulo da Silva et al. Baseline glycolytic tumor burden predicts response and survival in NSCLC and melanoma patients treated with immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1136/jitc-2021-SITC2021.055. Acesso em: 06 nov. 2024. , 2021
APA
Cordeiro, S. da S., Wanderley, C. W. de S., Marin, J. F. G., Macedo, M. de, Nascimento, E., Antonacio, F. F., et al. (2021). Baseline glycolytic tumor burden predicts response and survival in NSCLC and melanoma patients treated with immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1136/jitc-2021-SITC2021.055
NLM
Cordeiro S da S, Wanderley CW de S, Marin JFG, Macedo M de, Nascimento E, Antonacio FF, Cunha F de Q, Castro Junior G de C. Baseline glycolytic tumor burden predicts response and survival in NSCLC and melanoma patients treated with immune checkpoint inhibitors [Internet]. Journal for ImmunoTherapy of Cancer. 2021 ; 9( 11): A62-A63.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/jitc-2021-SITC2021.055
Vancouver
Cordeiro S da S, Wanderley CW de S, Marin JFG, Macedo M de, Nascimento E, Antonacio FF, Cunha F de Q, Castro Junior G de C. Baseline glycolytic tumor burden predicts response and survival in NSCLC and melanoma patients treated with immune checkpoint inhibitors [Internet]. Journal for ImmunoTherapy of Cancer. 2021 ; 9( 11): A62-A63.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/jitc-2021-SITC2021.055
Artigo de periodico
Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus (2020)
Morais-Faria, Karina; Palmier, Natalia Rangel; Correia, Jaqueline de Lima; Castro Junior, Gilberto de Castro ; Dias, Reinaldo Brito; Pinto, Henrique da Graca; Lopes, Marcio Ajudarte; Ribeiro, Ana Carolina Prado; Brandao, Thais Bianca; Santos-Silva, Alan Roger
Source: Supportive care in cancer. Unidade: FM
Subjects: ESTOMATITE, ESTUDOS RETROSPECTIVOS, ESTUDOS DE COORTES, NEOPLASIAS DE CABEÇA E PESCOÇO, RADIOTERAPIA, TRISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS-FARIA, Karina et al. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, v. 28, n. 9, p. 4345-4352, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00520-019-05241-x. Acesso em: 06 nov. 2024.
APA
Morais-Faria, K., Palmier, N. R., Correia, J. de L., Castro Junior, G. de C., Dias, R. B., Pinto, H. da G., et al. (2020). Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, 28( 9), 4345-4352. doi:10.1007/s00520-019-05241-x
NLM
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-019-05241-x
Vancouver
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-019-05241-x
Artigo de periodico-carta/editorial
Head and neck surgery recommendations during the COVID-19 pandemic [Carta] (2020)
Galloway, Thomas J; Kowalski, Luiz Paulo ; Matos, Leandro L; Castro Junior, Gilberto de Castro ; Ridge, John A
Source: Lancet oncology. Unidade: FM
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, PANDEMIAS, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALLOWAY, Thomas J et al. Head and neck surgery recommendations during the COVID-19 pandemic [Carta]. Lancet oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/37600. Acesso em: 06 nov. 2024. , 2020
APA
Galloway, T. J., Kowalski, L. P., Matos, L. L., Castro Junior, G. de C., & Ridge, J. A. (2020). Head and neck surgery recommendations during the COVID-19 pandemic [Carta]. Lancet oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://observatorio.fm.usp.br/handle/OPI/37600
NLM
Galloway TJ, Kowalski LP, Matos LL, Castro Junior G de C, Ridge JA. Head and neck surgery recommendations during the COVID-19 pandemic [Carta] [Internet]. Lancet oncology. 2020 ; 21( 9): E416-E416.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/37600
Vancouver
Galloway TJ, Kowalski LP, Matos LL, Castro Junior G de C, Ridge JA. Head and neck surgery recommendations during the COVID-19 pandemic [Carta] [Internet]. Lancet oncology. 2020 ; 21( 9): E416-E416.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/37600
Artigo de periodico
Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC (2020)
Cronemberger, Eduardo; Baldotto, Clarissa; Marinho, Felipe; Marchi, Pedro De; Araujo, Luiz Henrique; Franke, Fabio; Salles, Paulo; Calabrich, Aknar; Almeida, Thais; Castro Junior, Gilberto de Castro
Source: Clinics. Unidade: FM
Subjects: NEOPLASIAS PULMONARES, QUIMIOTERAPIA, GENÉTICA, TÉCNICAS DE DIAGNÓSTICO MOLECULAR, MUTAÇÃO, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRONEMBERGER, Eduardo et al. Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1777. Acesso em: 06 nov. 2024.
APA
Cronemberger, E., Baldotto, C., Marinho, F., Marchi, P. D., Araujo, L. H., Franke, F., et al. (2020). Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC. Clinics, 75. doi:10.6061/clinics/2020/e1777
NLM
Cronemberger E, Baldotto C, Marinho F, Marchi PD, Araujo LH, Franke F, Salles P, Calabrich A, Almeida T, Castro Junior G de C. Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 06 ] Available from: https://doi.org/10.6061/clinics/2020/e1777
Vancouver
Cronemberger E, Baldotto C, Marinho F, Marchi PD, Araujo LH, Franke F, Salles P, Calabrich A, Almeida T, Castro Junior G de C. Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 06 ] Available from: https://doi.org/10.6061/clinics/2020/e1777
Artigo de periodico
Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis (2020)
Mariz, Bruno Augusto Linhares Almeida; Kowalski, Luiz Paulo ; William Junior, William Nassib; Castro Junior, Gilberto de Castro ; Chaves, Aline Lauda Freitas; Santos, Marcos; Oliveira, Thiago Bueno de; Araujo, Anna Luiza Damaceno; Normando, Ana Gabriela Costa; Ribeiro, Ana Carolina Prado
Source: Critical reviews in oncology hematology. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO, PAPILLOMAVIRIDAE, INFECÇÕES POR PAPILLOMAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIZ, Bruno Augusto Linhares Almeida et al. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis. Critical reviews in oncology hematology, v. 156, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.critrevonc.2020.103116. Acesso em: 06 nov. 2024.
APA
Mariz, B. A. L. A., Kowalski, L. P., William Junior, W. N., Castro Junior, G. de C., Chaves, A. L. F., Santos, M., et al. (2020). Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis. Critical reviews in oncology hematology, 156. doi:10.1016/j.critrevonc.2020.103116
NLM
Mariz BALA, Kowalski LP, William Junior WN, Castro Junior G de C, Chaves ALF, Santos M, Oliveira TB de, Araujo ALD, Normando AGC, Ribeiro ACP. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis [Internet]. Critical reviews in oncology hematology. 2020 ; 156[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.critrevonc.2020.103116
Vancouver
Mariz BALA, Kowalski LP, William Junior WN, Castro Junior G de C, Chaves ALF, Santos M, Oliveira TB de, Araujo ALD, Normando AGC, Ribeiro ACP. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis [Internet]. Critical reviews in oncology hematology. 2020 ; 156[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.critrevonc.2020.103116
Artigo de periodico-carta/editorial
Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial] (2020)
Chaves, Aline Lauda Freitas; Castro, Ana Ferreira; Marta, Gustavo Nader; Castro Junior, Gilberto de Castro ; Ferris, Robert L; Giglio, Raul Eduardo; Golusinski, Wojciech; Gorphe, Philippe; Hosal, Sefik; Kowalski, Luiz Paulo
Source: Oral oncology. Unidade: FM
Subjects: CONTROLE DE INFECÇÕES, FATORES DE RISCO, INFECÇÕES POR CORONAVIRUS, NEOPLASIAS DE CABEÇA E PESCOÇO, RESULTADO DE TRATAMENTO, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Aline Lauda Freitas et al. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial]. Oral oncology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.oraloncology.2020.104734. Acesso em: 06 nov. 2024. , 2020
APA
Chaves, A. L. F., Castro, A. F., Marta, G. N., Castro Junior, G. de C., Ferris, R. L., Giglio, R. E., et al. (2020). Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial]. Oral oncology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.oraloncology.2020.104734
NLM
Chaves ALF, Castro AF, Marta GN, Castro Junior G de C, Ferris RL, Giglio RE, Golusinski W, Gorphe P, Hosal S, Kowalski LP. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial] [Internet]. Oral oncology. 2020 ; 107[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2020.104734
Vancouver
Chaves ALF, Castro AF, Marta GN, Castro Junior G de C, Ferris RL, Giglio RE, Golusinski W, Gorphe P, Hosal S, Kowalski LP. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial] [Internet]. Oral oncology. 2020 ; 107[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2020.104734
Artigo de periodico
Lung Cancer and the COVID-19 pandemic: recommendations from the Brazilian Thoracic Oncology Group (2020)
Baldotto, Clarissa; Gelatti, Ana; Accioly, Arthur; Mathias, Clarissa; Mascarenhas, Eldsamira; Carvalho, Heloisa; Faroni, Lilian; Araujo, Luiz Henrique; Terra, Ricardo Mingarini ; Castro Junior, Gilberto de Castro
Source: Clinics. Unidade: FM
Subjects: CORONAVIRUS, NEOPLASIAS PULMONARES, VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALDOTTO, Clarissa et al. Lung Cancer and the COVID-19 pandemic: recommendations from the Brazilian Thoracic Oncology Group. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e2060. Acesso em: 06 nov. 2024.
APA
Baldotto, C., Gelatti, A., Accioly, A., Mathias, C., Mascarenhas, E., Carvalho, H., et al. (2020). Lung Cancer and the COVID-19 pandemic: recommendations from the Brazilian Thoracic Oncology Group. Clinics, 75. doi:10.6061/clinics/2020/e2060
NLM
Baldotto C, Gelatti A, Accioly A, Mathias C, Mascarenhas E, Carvalho H, Faroni L, Araujo LH, Terra RM, Castro Junior G de C. Lung Cancer and the COVID-19 pandemic: recommendations from the Brazilian Thoracic Oncology Group [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 06 ] Available from: https://doi.org/10.6061/clinics/2020/e2060
Vancouver
Baldotto C, Gelatti A, Accioly A, Mathias C, Mascarenhas E, Carvalho H, Faroni L, Araujo LH, Terra RM, Castro Junior G de C. Lung Cancer and the COVID-19 pandemic: recommendations from the Brazilian Thoracic Oncology Group [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 06 ] Available from: https://doi.org/10.6061/clinics/2020/e2060
Artigo de periodico
Effect of the COVID-19 Pandemic on the Activity of Physicians Working in the Areas of Head and Neck Surgery and Otorhinolaryngology (2020)
Kowalski, Luiz Paulo ; Imamura, Rui; Castro Junior, Gilberto de Castro ; Marta, Gustavo Nader; Chaves, Aline Lauda Freitas; Matos, Leandro Luongo; Bento, Ricardo Ferreira
Source: International archives of otorhinolaryngology. Unidade: FM
Subjects: COVID-19, PANDEMIAS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOWALSKI, Luiz Paulo et al. Effect of the COVID-19 Pandemic on the Activity of Physicians Working in the Areas of Head and Neck Surgery and Otorhinolaryngology. International archives of otorhinolaryngology, v. 24, n. 3, p. 258-266, 2020Tradução . . Disponível em: https://doi.org/10.1055/s-0040-1712169. Acesso em: 06 nov. 2024.
APA
Kowalski, L. P., Imamura, R., Castro Junior, G. de C., Marta, G. N., Chaves, A. L. F., Matos, L. L., & Bento, R. F. (2020). Effect of the COVID-19 Pandemic on the Activity of Physicians Working in the Areas of Head and Neck Surgery and Otorhinolaryngology. International archives of otorhinolaryngology, 24( 3), 258-266. doi:10.1055/s-0040-1712169
NLM
Kowalski LP, Imamura R, Castro Junior G de C, Marta GN, Chaves ALF, Matos LL, Bento RF. Effect of the COVID-19 Pandemic on the Activity of Physicians Working in the Areas of Head and Neck Surgery and Otorhinolaryngology [Internet]. International archives of otorhinolaryngology. 2020 ; 24( 3): 258-266.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1055/s-0040-1712169
Vancouver
Kowalski LP, Imamura R, Castro Junior G de C, Marta GN, Chaves ALF, Matos LL, Bento RF. Effect of the COVID-19 Pandemic on the Activity of Physicians Working in the Areas of Head and Neck Surgery and Otorhinolaryngology [Internet]. International archives of otorhinolaryngology. 2020 ; 24( 3): 258-266.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1055/s-0040-1712169
Artigo de periodico
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study (2020)
Gruenwald, Viktor; Chirovsky, Diana; Cheung, Winson Y; Bertolini, Federica; Ahn, Myung-Ju; Yang, Muh-Hwa; Castro Junior, Gilberto de Castro ; Berrocal, Alfonso; Sjoquist, Katrin
Source: Oral oncology. Unidade: FM
Subjects: QUIMIOTERAPIA, CONDUTAS NA PRÁTICA DOS MÉDICOS, RECIDIVA, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRUENWALD, Viktor et al. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study. Oral oncology, v. 102, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2019.104526. Acesso em: 06 nov. 2024.
APA
Gruenwald, V., Chirovsky, D., Cheung, W. Y., Bertolini, F., Ahn, M. -J., Yang, M. -H., et al. (2020). Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study. Oral oncology, 102. doi:10.1016/j.oraloncology.2019.104526
NLM
Gruenwald V, Chirovsky D, Cheung WY, Bertolini F, Ahn M-J, Yang M-H, Castro Junior G de C, Berrocal A, Sjoquist K. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study [Internet]. Oral oncology. 2020 ; 102[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.104526
Vancouver
Gruenwald V, Chirovsky D, Cheung WY, Bertolini F, Ahn M-J, Yang M-H, Castro Junior G de C, Berrocal A, Sjoquist K. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study [Internet]. Oral oncology. 2020 ; 102[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.104526
Artigo de periodico
The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer (2019)
Marchi, Pedro De; Melendez, Matias E; Laus, Ana C; Kuhlmann, Pamela A; Carvalho, Ana Carolina de; Arantes, Lidia Maria R. B; Evangelista, Adriane F; Andrade, Edilene S; Castro Junior, Gilberto de Castro ; Reis, Rui M
Source: Oral oncology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, POLIMORFISMO, CARCINOMA DE CÉLULAS ESCAMOSAS, SEQUENCIAMENTO GENÉTICO, QUIMIOTERAPIA, ANTINEOPLÁSICOS, PROTEÍNAS DE TRANSPORTE, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHI, Pedro De et al. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, v. 98, p. 48-52, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2019.09.013. Acesso em: 06 nov. 2024.
APA
Marchi, P. D., Melendez, M. E., Laus, A. C., Kuhlmann, P. A., Carvalho, A. C. de, Arantes, L. M. R. B., et al. (2019). The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, 98, 48-52. doi:10.1016/j.oraloncology.2019.09.013
NLM
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013
Vancouver
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013
Artigo de periodico
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study (2019)
Burtness, Barbara; Harrington, Kevin J; Greil, Richard; Soulieres, Denis; Tahara, Makoto; Castro Junior, Gilberto de Castro ; Psyrri, Amanda; Baste, Neus; Neupane, Prakash; Bratland, Ase
Source: Lancet. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO, ANTICORPOS MONOCLONAIS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURTNESS, Barbara et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, v. 394, n. 10212, p. 1915-1928, 2019Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(19)32591-7. Acesso em: 06 nov. 2024.
APA
Burtness, B., Harrington, K. J., Greil, R., Soulieres, D., Tahara, M., Castro Junior, G. de C., et al. (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, 394( 10212), 1915-1928. doi:10.1016/S0140-6736(19)32591-7
NLM
Burtness B, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Baste N, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study [Internet]. Lancet. 2019 ; 394( 10212): 1915-1928.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(19)32591-7
Vancouver
Burtness B, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Baste N, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study [Internet]. Lancet. 2019 ; 394( 10212): 1915-1928.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(19)32591-7
Artigo de periodico
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies (2019)
Nosaki, Kaname; Saka, Hideo; Hosomi, Yukio; Baas, Paul; Castro Junior, Gilberto de Castro ; Reck, Martin; Wu, Yi-Long; Brahmer, Julie R; Felip, Enriqueta; Sawada, Takeshi
Source: Lung cancer. Unidade: FM
Subjects: NEOPLASIAS PULMONARES, CARCINOMA BRONCOGÊNICO, IMUNOTERAPIA, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSAKI, Kaname et al. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies. Lung cancer, v. 135, p. 188-195, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.lungcan.2019.07.004. Acesso em: 06 nov. 2024.
APA
Nosaki, K., Saka, H., Hosomi, Y., Baas, P., Castro Junior, G. de C., Reck, M., et al. (2019). Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies. Lung cancer, 135, 188-195. doi:10.1016/j.lungcan.2019.07.004
NLM
Nosaki K, Saka H, Hosomi Y, Baas P, Castro Junior G de C, Reck M, Wu Y-L, Brahmer JR, Felip E, Sawada T. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies [Internet]. Lung cancer. 2019 ; 135 188-195.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.lungcan.2019.07.004
Vancouver
Nosaki K, Saka H, Hosomi Y, Baas P, Castro Junior G de C, Reck M, Wu Y-L, Brahmer JR, Felip E, Sawada T. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies [Internet]. Lung cancer. 2019 ; 135 188-195.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.lungcan.2019.07.004
Artigo de periodico
Non-gastrointestinal stromal tumours soft tissue sarcomas: an update (2019)
Matos, Gustavo Duarte Ramos; Camargo, Veridiana Pires de; Munhoz, Rodrigo Ramella; Castro Junior, Gilberto de Castro
Source: Ecancermedicalscience. Unidade: FM
Subjects: SARCOMA, NEOPLASIAS DE TECIDOS MOLES, CÉLULAS ESTROMAIS, CÉLULAS-TRONCO, CÉLULAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS, Gustavo Duarte Ramos et al. Non-gastrointestinal stromal tumours soft tissue sarcomas: an update. Ecancermedicalscience, v. 13, 2019Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2019.958. Acesso em: 06 nov. 2024.
APA
Matos, G. D. R., Camargo, V. P. de, Munhoz, R. R., & Castro Junior, G. de C. (2019). Non-gastrointestinal stromal tumours soft tissue sarcomas: an update. Ecancermedicalscience, 13. doi:10.3332/ecancer.2019.958
NLM
Matos GDR, Camargo VP de, Munhoz RR, Castro Junior G de C. Non-gastrointestinal stromal tumours soft tissue sarcomas: an update [Internet]. Ecancermedicalscience. 2019 ; 13[citado 2024 nov. 06 ] Available from: https://doi.org/10.3332/ecancer.2019.958
Vancouver
Matos GDR, Camargo VP de, Munhoz RR, Castro Junior G de C. Non-gastrointestinal stromal tumours soft tissue sarcomas: an update [Internet]. Ecancermedicalscience. 2019 ; 13[citado 2024 nov. 06 ] Available from: https://doi.org/10.3332/ecancer.2019.958

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies